Nasdaq:gild articles
-
McIlrath & Eck LLC Grows Holdings in Gilead Sciences, Inc. (NASDAQ:GILD)
McIlrath & Eck LLC lifted its holdings in Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 67.2% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 550 shares of the biopharmaceutical company’s stock after buying an additional 221 shares during the quarter. McIlrath […]
-
Victory Capital Management Inc. Has $201.69 Million Position in Gilead Sciences, Inc. (NASDAQ:GILD)
Victory Capital Management Inc. boosted its holdings in Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 7.7% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 2,489,705 shares of the biopharmaceutical company’s stock after purchasing an additional 178,536 shares during the quarter. […]
-
New York Life Investment Management LLC Has $15.94 Million Stock Holdings in Gilead Sciences, Inc. (NASDAQ:GILD)
New York Life Investment Management LLC decreased its position in Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 12.2% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 196,816 shares of the biopharmaceutical company’s stock after selling 27,356 shares during the […]